Safety of Intraparenchymal Injection of Allogenic Placenta Mesenchymal Stem Cells Derived Exosome in Patients Undergoing Decompressive Craniectomy Following Malignant Middle Cerebral Artery Infarct, A Pilot Randomized Clinical Trial

BACKGROUND: Malignant middle cerebral artery infarct (mMCAI) largely contributes to high mortality and physical disability among adults. Surviving individuals may not have proper outcomes and suffer from severe lasting disabilities. Utilization of stem cells and paracrine factor for regenerative pur...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehghani, Leila, Khojasteh, Arash, Soleimani, Masoud, Oraee-Yazdani, Saeed, Keshel, Saeed Heidari, Saadatnia, Mohammad, Saboori, Masih, Zali, Alireza, Hashemi, Seyed Mahmoud, Soleimani, Reyhane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883670/
https://www.ncbi.nlm.nih.gov/pubmed/35281985
http://dx.doi.org/10.4103/ijpvm.ijpvm_441_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883670/
https://www.ncbi.nlm.nih.gov/pubmed/35281985
http://dx.doi.org/10.4103/ijpvm.ijpvm_441_21

Ejemplares similares